Reference
Institute for Clinical and Economic Review. Institute for Clinical and Economic Review report finds inadequate evidence to distinguish between anabolic therapies for osteoporosis. Internet Document : 16 Jun 2017. Available from: URL: https://icer-review.org/announcements/osteo-evidence-report/
Rights and permissions
About this article
Cite this article
ICER review finds abaloparatide and teriparatide too costly. PharmacoEcon Outcomes News 781, 4 (2017). https://doi.org/10.1007/s40274-017-4096-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-4096-3